Articles written by: Clifton Ray

Key Analysts at Needham Kept the Same their ‘”Strong Buy”’ rating for Genomic Health (NASDAQ:GHDX) Shares Today. Their PT is Set to $97

Key Analysts at Needham Kept the Same their ‘”Strong Buy”’ rating for Genomic Health (NASDAQ:GHDX) Shares Today. Their PT is Set to $97

Investors sentiment increased to 2.23 in Q3 2018. Its up 0.30, from 1.93 in 2018Q2. It increased, as 8 investors sold Genomic Health, Inc. shares while 40 reduced holdings. 55 funds opened positions (more…)

Idera Pharmaceuticals, Inc. (IDRA) EPS Estimated At $-0.49

Idera Pharmaceuticals, Inc. (IDRA) EPS Estimated At $-0.49

Investors sentiment decreased to 0.01 in 2018 Q3. Its down 1.06, from 1.07 in 2018Q2. It fall, as 68 investors sold Idera Pharmaceuticals, Inc. shares while 2 reduced holdings. 1 funds opened positions (more…)

Breaking: Arbuthnot Banking Group (LON:ARBB) “Buy” Rating Reconfirmed by Analysts at Numis Today; The TP Given is GBX 1706.00

Arbuthnot Banking Group (LON:ARBB) Rating Reaffirmed Numis now has a GBX 1706.00 target on shares of Arbuthnot Banking Group (LON:ARBB). The target gives a potential upside of 34.23 % from the last stock (more…)

Analysts See $-0.33 EPS for Axsome Therapeutics, Inc. (AXSM)

Analysts See $-0.33 EPS for Axsome Therapeutics, Inc. (AXSM)

Analysts expect Axsome Therapeutics, Inc. (NASDAQ:AXSM) to report $-0.33 EPS on March, 6.They anticipate $0.05 EPS change or 17.86 % from last quarter’s $-0.28 EPS. After having $-0.31 EPS previously, (more…)

Needham Reiterates SurModics (NASDAQ:SRDX) As a “Buy”; They Now Have a Price Target Of $74

Needham Reiterates SurModics (NASDAQ:SRDX) As a “Buy”; They Now Have a Price Target Of $74

Investors sentiment increased to 1.94 in 2018 Q3. Its up 0.09, from 1.85 in 2018Q2. It increased, as 11 investors sold Surmodics, Inc. shares while 36 reduced holdings. 36 funds opened positions while (more…)

Cas Medical Systems Inc: Edwards Lifesciences Holding, Inc Opened Position

Cas Medical Systems Inc: Edwards Lifesciences Holding, Inc Opened Position

Investors sentiment increased to 3.75 in Q3 2018. Its up 2.08, from 1.67 in 2018Q2. It is positive, as 2 investors sold CAS Medical Systems, Inc. shares while 2 reduced holdings. 6 funds opened positions (more…)

Materialise NV (MTLS) EPS Estimated At $0.05

Materialise NV (MTLS) EPS Estimated At $0.05

Analysts expect Materialise NV (NASDAQ:MTLS) to report $0.05 EPS on March, 5.They anticipate $0.01 EPS change or 25.00 % from last quarter’s $0.04 EPS. MTLS’s profit would be $2.62 million giving it 91.40 (more…)

Analysts See $1.04 EPS for Turtle Beach Corporation (HEAR)

Analysts See $1.04 EPS for Turtle Beach Corporation (HEAR)

Analysts expect Turtle Beach Corporation (NASDAQ:HEAR) to report $1.04 EPS on March, 5.They anticipate $0.12 EPS change or 10.34 % from last quarter’s $1.16 EPS. HEAR’s profit would be $14.81 million (more…)